How do I buy Viridian Therapeutics (VRDN) stock?

You can purchase shares of Viridian Therapeutics (NASDAQ:VRDN) through any online brokerage.View our list of the best stock brokerages

Who are Viridian Therapeutics (VRDN) competitors?

Other companies in Viridian Therapeutics’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Legend Biotech Corp (NASDAQ:LEGN), Twist Bioscience Corp (NASDAQ:TWST), Centessa Pharmaceuticals PLC (NASDAQ:CNTA) and Ascentage Pharma Group International (NASDAQ:AAPG).

What is the forecast, or price target, for Viridian Therapeutics (VRDN) stock?

Viridian Therapeutics has a consensus price target of $40.65.

What is the current price for Viridian Therapeutics (VRDN)?

The stock price for Viridian Therapeutics (NASDAQ: VRDN) is $33.2 last updated January 16, 2026 at 5:02 PM EST.

Does Viridian Therapeutics (VRDN) pay a dividend?

There are no upcoming dividends for Viridian Therapeutics.

When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?

Viridian Therapeutics does not have any upcoming earnings scheduled.

Is Viridian Therapeutics (VRDN) going to split?

There is no upcoming split for Viridian Therapeutics.

What sector and industry does Viridian Therapeutics (VRDN) operate in?

Viridian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Viridian Therapeutics (VRDN) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-00...

Comments